PEGylated Protein Therapeutics Market by Product Type (Colony Stimulating Factor, Interferon, Erythropoietin (EPO), Recombinant Factor VIII, Monoclonal Antibody, Enzyme, and Others) By Application (Cancer, Autoimmune Disease, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorder, and Others) By Sales Channel (Hospital Pharmacy, Online Provider, and Retail Pharmacy) - Global Opportunity Analysis and Industry Forecast, 2018-2025

Market: Pharmaceuticals

, 166 pages report, published by Allied Market Research

Report ThumbnailAugust-2018
PEGylation refers to the process of amalgamation or attachment of polyethylene glycol (PEG) polymer chains with macromolecules, such as drug molecule, therapeutic protein, or vesicles by covalent bonding. PEGylation offers several advantages, such as improved drug solubility, reduced dosage frequency, and increased drug stability, which boost its demand in the market.

The global PEGylated protein therapeutics market was valued at $10,388 million in 2017, and is estimated to reach at $17,813 mil

Read More
  • FIGURE 01. PEGYLATED PROTEIN THERAPEUTICS MARKET SEGMENTATION
  • FIGURE 02. TOP INVESTMENT POCKETS
  • FIGURE 03. TOP PLAYER POSITIONING, 2017
  • FIGURE 04. IMPACT ANALYSES, PEGYLATED PROTEIN THEREPEUTICS MARKET
  • FIGURE 05. U.S. PEGYLATED PROTEIN THERAPEUTICS MARKET, 2017-2025 ($MILLION)
  • FIGURE 06. REST OF NORTH AMERICA PEGYLATED PROTEIN THERAPEUTICS MARKET, 2017-2025 ($MILLION)
  • FIGURE 07. GERMANY PEGYLATED PROTEIN THERAPEUTICS MARKET, 2017-2025 ($MILLION)
  • FIGURE 08. FRANCE PEGYLATED PROTEIN THERAPEUTICS M
Read More
  • TABLE 01. COMPLETED CLINICAL TRIALS IN PEGYLATED PROTEIN THERAPEUTICS MARKET, 2013-2018
  • TABLE 02. GLOBAL PEGYLATED PROTEIN THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
  • TABLE 03. PEGYLATED COLONY STIMULATING FACTOR MARKET, BY REGION, 2017-2025 ($MILLION)
  • TABLE 04. PEGYLATED INTERFERONS MARKET, BY REGION, 2017-2025 ($MILLION)
  • TABLE 05. PEGYLATED ERYTHROPOIETIN MARKET, BY REGION, 2017-2025 ($MILLION)
  • TABLE 06. PEGYLATED RECOMBINANT FACTOR VIII MARKET, BY REGION, 2017-2025 ($MILLION)
  • T
Read More
  • CHAPTER 1: INTRODUCTION
  • 1.1. Report Description
  • 1.2. Key Benefits for Stakeholders
  • 1.3. Key Market Segments
  • 1.3.1. List of key players profiled in the report
  • 1.4. Research Methodology
  • 1.4.1. Secondary research
  • 1.4.2. Primary research
  • 1.4.3. Analyst tools and models
  • CHAPTER 2: EXECUTIVE SUMMARY
  • 2.1. Key Findings of the Study
  • 2.2. CXO Perspective
  • CHAPTER 3: MARKET OVERVIEW
  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
  • 3.2.1. Top investment pockets
  • 3.3. Top Player Positioning, 2017
  • 3
Read More
  • According to a new report published by Allied Market Research, titled, " PEGylated Protein Therapeutics Market by Product Type, Application, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018-2025, the market was valued at $10,388 million in 2017, and is projected to reach $17,813 million by 2025, growing at a CAGR of 6.9% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.

    PEGylation is a process of addit
Read More

Related Products

Allied Market ResearchPEGylated Protein Therapeutics Market by Product Type (Colony Stimulating Factor, Interferon, Erythropoietin (EPO), Recombinant Factor VIII, Monoclonal Antibody, Enzyme, and Others) By Application (Cancer, Autoimmune Disease, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorder, and Others) By Sales Channel (Hospital Pharmacy, Online Provider, and Retail Pharmacy) - Global Opportunity Analysis and Industry Forecast, 2018-2025 Product ThumbnailPEGylated Protein Therapeutics Market by Product Type (Colony Stimulating Factor, Interferon, Erythropoietin (EPO), Recombinant Factor VIII, Monoclonal Antibody, Enzyme, and Others) By Application (Cancer, Autoimmune Disease, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorder, and Others) By Sales Channel (Hospital Pharmacy, Online Provider, and Retail Pharmacy) - Global Opportunity Analysis and Industry Forecast, 2018-2025 , Industry ReportProduct #: 1185686
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2020 Global Market Analyst. All Rights Reserved